127 related articles for article (PubMed ID: 35278613)
1. Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer.
Yan R; Dai W; Wu R; Huang H; Shu M
Cancer Lett; 2022 May; 534():215615. PubMed ID: 35278613
[TBL] [Abstract][Full Text] [Related]
2. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
[TBL] [Abstract][Full Text] [Related]
3. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
Zhang F; Yan Y; Cao X; Zhang J; Li Y; Guo C
Aging (Albany NY); 2021 Apr; 13(8):12224-12238. PubMed ID: 33882457
[TBL] [Abstract][Full Text] [Related]
4. METTL3 promotes IL-1β-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.
Xiao L; Zhao Q; Hu B; Wang J; Liu C; Xu H
J Cell Mol Med; 2020 Dec; 24(23):14013-14025. PubMed ID: 33098220
[TBL] [Abstract][Full Text] [Related]
5. METTL3 inhibition ameliorates liver damage in mouse with hepatitis B virus-associated acute-on-chronic liver failure by regulating miR-146a-5p maturation.
Cheng D; Wu C; Li Y; Liu Y; Mo J; Fu L; Peng S
Biochim Biophys Acta Gene Regul Mech; 2022 Apr; 1865(3):194782. PubMed ID: 34968770
[TBL] [Abstract][Full Text] [Related]
6. METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer.
Liu J; Jiang K
J Cell Mol Med; 2022 May; 26(9):2505-2519. PubMed ID: 35348293
[TBL] [Abstract][Full Text] [Related]
7. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.
Peng W; Li J; Chen R; Gu Q; Yang P; Qian W; Ji D; Wang Q; Zhang Z; Tang J; Sun Y
J Exp Clin Cancer Res; 2019 Sep; 38(1):393. PubMed ID: 31492150
[TBL] [Abstract][Full Text] [Related]
8. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
Li S; Lu X; Zheng D; Chen W; Li Y; Li F
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
[TBL] [Abstract][Full Text] [Related]
9. METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8.
Gong WJ; Li R; Dai QQ; Yu P
J Gastroenterol Hepatol; 2022 Dec; 37(12):2229-2242. PubMed ID: 36068012
[TBL] [Abstract][Full Text] [Related]
10. METTL3 promotes non-small-cell lung cancer growth and metastasis by inhibiting FDX1 through copper death-associated pri-miR-21-5p maturation.
Qian S; Liu J; Liao W; Wang F
Epigenomics; 2023 Dec; 15(23):1237-1255. PubMed ID: 38126112
[TBL] [Abstract][Full Text] [Related]
11. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
[TBL] [Abstract][Full Text] [Related]
12. miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.
Wu H; Li F; Zhu R
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):304-316. PubMed ID: 33355622
[TBL] [Abstract][Full Text] [Related]
13. Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection.
Sasaki H; Yoshiike M; Nozawa S; Usuba W; Katsuoka Y; Aida K; Kitajima K; Kudo H; Hoshikawa M; Yoshioka Y; Kosaka N; Ochiya T; Chikaraishi T
Clin Genitourin Cancer; 2016 Oct; 14(5):e493-e499. PubMed ID: 27157639
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LINC00240 promotes gastric cancer progression via modulating miR-338-5p/METTL3 axis.
Wang G; Zhang Z; Xia C
Bioengineered; 2021 Dec; 12(2):9678-9691. PubMed ID: 34842045
[TBL] [Abstract][Full Text] [Related]
15. Cancer-Associated Fibroblast-Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance.
Zhuang J; Shen L; Li M; Sun J; Hao J; Li J; Zhu Z; Ge S; Zhang D; Guo H; Huang R; Yan J
Cancer Res; 2023 May; 83(10):1611-1627. PubMed ID: 36939397
[TBL] [Abstract][Full Text] [Related]
16. lncRNA MORT Regulates Bladder Cancer Behaviors by Downregulating MicroRNA-146a-5p.
Wang Y; Sun Q; Ji L; Wang G; Niu X; Sun S
Nephron; 2020; 144(7):351-357. PubMed ID: 32554962
[TBL] [Abstract][Full Text] [Related]
17. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
[TBL] [Abstract][Full Text] [Related]
18. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
[TBL] [Abstract][Full Text] [Related]
19. Methyltransferase-like 3-mediated N6-methyladenosine modification of miR-7212-5p drives osteoblast differentiation and fracture healing.
Mi B; Xiong Y; Yan C; Chen L; Xue H; Panayi AC; Hu L; Hu Y; Zhou W; Cao F; Liu G
J Cell Mol Med; 2020 Jun; 24(11):6385-6396. PubMed ID: 32307908
[TBL] [Abstract][Full Text] [Related]
20. METTL3/N6-methyladenosine/ miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-κB pathway activation.
Liu E; Lv L; Zhan Y; Ma Y; Feng J; He Y; Wen Y; Zhang Y; Pu Q; Ji F; Yang X; Wen JG
J Cell Mol Med; 2021 Aug; 25(16):7660-7674. PubMed ID: 34164910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
